Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03228147 · ClinicalTrials.gov registry record · NA

Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment

A NA study of Malignant Neoplasm and Esophagitis, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03228147 is a NA study of Malignant Neoplasm and Esophagitis that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03228147, a NA study of Malignant Neoplasm and Esophagitis, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies sensory evaluation of oral nutrition supplements in patients at risk for mucositis undergoing cancer treatment. Sensory evaluation may help to obtain input about new oral nutritional supplements that may increase nutrient intake and maintain or improve nutritional status, functional capacity, and quality of life in cancer patients.

Interventions

  • OTHER Questionnaire Administration
  • DIETARY_SUPPLEMENT Nutritional Supplementation

Study Locations (1)

New Jersey

  • Rutgers Cancer Institute of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-07-25
Est. Completion 2017-10-31
Phase NA

What the Registry Record Tells You About NCT03228147

The ClinicalTrials.gov registry entry for NCT03228147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (94% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT03228147 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03228147 about?

NCT03228147 is a clinical study titled "Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment". This pilot clinical trial studies sensory evaluation of oral nutrition supplements in patients at risk for mucositis undergoing cancer treatment. Sensory evaluation may help to obtain input about new oral nutritional supplements that may increase nutrient intake and maintain or improve nutritional s...

What is the current status of trial NCT03228147?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-07-25. Estimated completion is 2017-10-31.

What conditions does trial NCT03228147 study?

This clinical trial studies the following conditions: Malignant Neoplasm, Esophagitis, Mucositis.

What interventions are being tested in trial NCT03228147?

The interventions under investigation include: Questionnaire Administration (OTHER), Nutritional Supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03228147?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03228147 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.